R. Gold

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

Reversible impaired memory induced by pulsed methylprednisolone in patients with MS

D. Ecker, S. Süssmuth, H. Tumani, 2005, Neurology.

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode

M. Abegg, T. Lücke, J. Havla, 2022, Journal of Neurology.